Blog

How Risky Are These Heavily Shorted COVID Stocks?

Short sellers have their eyes peeled on Vir Biotechnology (NASDAQ: VIR) and Sorrento Therapeutics (NASDAQ: SRNE). Short positions make up 22% and 26% of their float, respectively. Float refers to

TheMotleyFool

0

3 Reasons Pfizer's Failures Could Lead to a Big Acquisition

When Pfizer (NYSE: PFE) included statistics in its recent earnings release showing its pipeline performance over the past five years, there was a not-so-subtle message. The blue-chip pharmaceutical

TheMotleyFool

0

3 Absurdly Cheap Coronavirus Stocks to Buy Now

Companies contributing to the fight against COVID-19 have received a lot of attention in the last year, but not all of their stocks have soared. For some businesses, the pandemic is providing an

TheMotleyFool

0

This Company Could Be a Big Winner of the Recent Short Squeezes

In the recent short squeezes that saw GameStop, AMC Entertainment Holdings, and several other stocks soar rapidly in extremely volatile trading, many investors were getting frustrated with trading

TheMotleyFool

0

How Bad News for Xeljanz Could Affect Pfizer's Fortunes

Pfizer (NYSE: PFE) has enjoyed plenty of good news lately with its successful COVID-19 vaccine. However, the big drugmaker recently announced disappointing results from a post-marketing safety study

TheMotleyFool

0

4 Disruptive Stocks to Buy and Hold for 10 Years

Over the long run, there's no better bang for your buck than the stock market. Despite undergoing numerous major corrections, including the dot-com bubble in the early 2000s, the Great Recession of

TheMotleyFool

0

Drama Is Beginning to Unfold at Berkshire Hills Bancorp. Will It Benefit Shareholders?

Life at the $12.8-billion-asset Berkshire Hills Bancorp (NYSE: BHLB) has been anything but dull over the past few years, whether you look at the bank's volatile stock price or its many leadership

TheMotleyFool

0

1 Pot Stock I'm Not Selling Even in a Market Crash

When share prices fall sharply, the initial reaction of many investors is to panic and sell otherwise solid investments. If you own volatile stocks like Canopy Growth and Aurora Cannabis, it can

TheMotleyFool

0

How Pacific Biosciences Beat Expectations in Q4

Pacific Biosciences of California (NASDAQ: PACB) no doubt made many investors happy in 2020, as its shares more than quintupled in value. The genetic sequencing systems stock is off to a great start

TheMotleyFool

0

Why Trupanion's Q4 Results Weren't the Cat's Meow

Trupanion (NASDAQ: TRUP) delivered sizzling returns last year, with its share price more than tripling in value. However, the stock hasn't been such a big winner so far in 2021.

That's probably not

TheMotleyFool

0

Women Worry More Than Men About Senior Healthcare Costs, Data Shows

It's no secret that healthcare is a huge expense for seniors. But new data from MedicareGuide.com reveals that women worry more about it than men.

In a recent survey of Medicare enrollees aged 65

TheMotleyFool

0

Half of Robinhood's Top 10 Stocks Could Implode in 2021

In eight days, we'll mark the one-year anniversary of the beginning of the coronavirus disease 2019 (COVID-19) crash on Wall Street. It took just 33 calendar days for the benchmark S&P 500 to lose

TheMotleyFool

0

Here's Your Chance to Earn a Tax Credit for Saving Toward Retirement

If you've been brushing off saving for retirement, here's one incentive that could inspire you to step up your retirement game: the Saver's Credit. It's a special reward that the IRS grants to low-

TheMotleyFool

0

Like Dividends? These 3 High-Yield Stocks Have Kept Shareholders Flush for More Than a Century

Many investors have no choice but to get much-needed cash from their investments. Traditionally, most investors turned to bonds and bank CDs to get the income they needed. However, with interest

TheMotleyFool

0